by Extivita | Apr 1, 2015 | Retinitis Pigmentosa
Abstract: Aims. Several treatments have been proposed to slow down progression of Retinitis pigmentosa (RP), a hereditary retinal degenerative condition leading to severe visual impairment. The aim of this study is to systematically review data from randomized...
by Extivita | Aug 3, 2014 | Retinitis Pigmentosa
Abstract: Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide....
by Extivita | Mar 12, 2007 | Retinitis Pigmentosa
Abstract: Retinitis pigmentosa (RP) therapy is still an unsolved challenge. Recent reports have underlined that hyperbaric oxygen (HBO) therapy could play a role in slowing the retinal degenerative process. The aim of this study was to assess the efficacy of HBO...
by Extivita | Oct 19, 2004 | Retinitis Pigmentosa
Abstract: Vision loss due to various forms of outer retinal degeneration remains a major problem in clinical ophthalmology. Most retinal degenerations are precipitated by genetic mutations affecting the retinal pigment epithelium and sensory retina, but it is becoming...
by Extivita | Mar 10, 2000 | Retinitis Pigmentosa
Abstract: As previously reported in the literature, hyperbaric oxygen delivery seems to modify the natural course of retinitis pigmentosa. In order to evaluate these first encouraging data, 48 affected subjects were separately studied in two subgroups (cases and...
by Extivita | Sep 10, 1994 | Retinitis Pigmentosa
Abstract: A 26 year old man, who was physically fit and occupationally active but had retinitis pigmentosa and a slight hearing impairment, received hyperbaric oxygen treatment for 97 minutes at a pressure of 240 kPA for five days a week over a period of four weeks....
